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ABSTRACT: Human mitoNEET is a homodimeric protein an-
chored to the outer mitochondrial membrane and with a C-terminal 
[2Fe-2S] binding domain located in the cytosol. Recently, human 
mitoNEET has been shown to be implicated in Fe/S cluster repair 
of the cytosolic iron regulatory protein 1 (IRP1), a key regulator of 
cellular iron homeostasis in mammalian cells. The Fe/S cluster re-
pairing function of mitoNEET is based on a Fe/S redox switch 
mechanism: under normal cellular conditions, reduced [2Fe-2S]+ 
mitoNEET is present and is inactive as Fe/S cluster transfer protein; 
under conditions of oxidative cellular stress, the clusters of mi-
toNEET become oxidized and the formed [2Fe-2S]2+ mitoNEET 
species reacts promptly to initiate Fe/S cluster transfer to IRP1 re-
cycling the cytosolic apo-IRP1 into holo-aconitase. Until now, no 
clear data are available on which is the system reducing back the 
mitoNEET clusters once oxidative stress is not present anymore. In 
the present work we investigated, by UV-visible and NMR spec-
troscopies, the electron transfer process between mitoNEET and 
the cytosolic electron-donor Ndor1-anamorsin complex, a compo-
nent of the cytosolic iron-sulfur protein assembly (CIA) machinery. 
The [2Fe-2S] clusters of mitoNEET are reduced via the formation 
of a transient complex, which brings the [2Fe-2S] clusters of mi-
toNEET close to the redox-active [2Fe-2S] cluster of anamorsin. 
Our data provide an in vitro evidence of a possible direct link be-
tween the CIA machinery and the mitoNEET-cluster transfer re-
pairing pathway. This link might contribute to recover CIA ma-
chinery efficiency to mature cytosolic and nuclear Fe/S proteins. 
MitoNEET is a small protein localized to the cytosolic face of the 
outer mitochondrial membrane by a single transmembrane helix.1 
MitoNEET forms dimers with one [2Fe-2S] cluster per monomer.2-
4 Various studies have shown that mitoNEET displays high affinity 
for the reduced [2Fe-2S]+ state of the cluster, while, once oxidized, 
the cluster is more labile.5-7 In-cell EPR studies showed that the 
[2Fe-2S] clusters of mitoNEET are in the reduced [2Fe-2S]+ state 
when expressed in E. coli cells under normal growth conditions, 
and, on this basis, it was assumed to be reduced in unstressed mam-
malian cells.8 This agrees with the high midpoint potential of the 
mitoNEET clusters, which is approximatively 0 mV at pH 7.0.9,10 
Recently, it has been proposed that mitoNEET plays a specific role 
in cytosolic Fe-S cluster repair of IRP1 in oxidative-stressed cells.11 
This pathway reactivates the cytosolic apo-IRP1 into Fe/S loaded, 
active aconitase after H2O2-induced oxidative and nitrosative 
stress, independently of the classic CIA-dependent Fe/S cluster bi-
ogenesis pathway, which matures aconitase under normal cellular 
conditions.12,13  Oxidative stress conditions induce oxidation of the 
mitoNEET [2Fe-2S] clusters, triggering their transfer to IRP1 and 
transforming it in active aconitase.11,14 Hence, mitoNEET may di-
rectly control its Fe/S cluster transfer activity via a redox switch of 
its redox active [2Fe-2S] clusters. While oxidative stress causes ox-
idation of mitoNEET clusters without their disruption,8,15 no clear 
data are available on which is the protein system reducing mi-
toNEET clusters thus re-establishing the resting reduced state, once 
oxidative stress is not present anymore. Bioinformatics analysis 
suggested flavoproteins as possible mitoNEET reductant.16,17 
Among them, the cytoplasmic NADPH-dependent diflavin oxi-
doreductase 1 (Ndor1), forms a stable complex with anamorsin 
both in vivo and in vitro.18-20 Anamorsin binds two [2Fe-2S] clus-
ters in two distinct Fe/S cluster binding sites.18,21,22 In the complex, 
Ndor1 reduces the [2Fe-2S] cluster bound to the first CX8CX2CXC 
motif (named redox-active cluster hereafter) of anamorsin.18,22 The 
reduced cluster provides electrons for assembling cytosolic iron-
sulfur cluster proteins, thus being an active player of the CIA ma-
chinery.19 In the present work we investigated electron transfer be-
tween mitoNEET and the Ndor1-anamorsin complex by UV-
visible and NMR spectroscopies. The FMN-binding domain of 
Ndor1 with FMN in the oxidized state (FMN-Ndor1, as obtained 
from the purification procedure, see Supporting Information), was 
first reduced anaerobically to obtain the fully reduced state of FMN 
with the addition of 2 equivalents of sodium dithionite. A PD-10 
desalting column was then performed in order to remove any resid-
ual dithionite, and the fully reduced state of the FMN-binding do-
main of Ndor1 (FMNH2-Ndor1) was mixed with [2Fe-2S]2+-ana-
morsin at a 1:1 ratio to reduce the redox-active cluster of anamorsin 
([2Fe-2S]+-anamorsin).18,22 Reduction of the [2Fe-2S] cluster was 
observed by monitoring the decrease in absorbance at 432 nm (i.e. 
the isosbestic point between FMNH2-Ndor1 and Ndor1 with FMN 
in the neutral blue semiquinone state, i.e. FMNH•-Ndor1, Figure 
S1).18 The final product upon cluster reduction is a hetero-complex 
formed by FMNH•-Ndor1 and [2Fe-2S]+-anamorsin. This FMNH•-
Ndor1/[2Fe-2S]+-anamorsin complex was then mixed with oxi-
dized [2Fe-2S]2+-mitoNEET at a 1:1 redox-active cluster ratio, and 
changes in absorbance at 501 nm (the isosbestic point between 
FMNH•-Ndor1 and FMN-Ndor1 species, Figure S1) were moni-
tored over time. The absorbance increased up to a plateau of 0.06, 
indicating the occurrence of an electron transfer reaction (Figure 
1a, Figure S2). At the isosbestic point of 501 nm, the oxidation of 
FMNH•-Ndor1 to FMN-Ndor1 does not contribute to the change in 
absorbance and therefore the observed increase of absorbance at 
501 nm results only from the other cofactors present in the hetero-
complex and in mitoNEET, i.e. the reduced [2Fe-2S]+ cluster of 
anamorsin and the oxidized [2Fe-2S]2+ clusters of mitoNEET. At 
the same protein concentration as that used in the electron transfer 
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between the FMNH•-Ndor1/[2Fe-2S]+-anamorsin complex and 
[2Fe-2S]2+-mitoNEET, the oxidation of the two [2Fe-2S]+ clusters 
of anamorsin to [2Fe-2S]2+ causes an increase in the absorbance at 
501 nm of 0.26 (Figure 1b), and the reduction of the two [2Fe-
2S]2+ clusters of mitoNEET to [2Fe-2S]+ causes a decrease in the 
absorbance at 501 nm of 0.15 (Figure 1c). Therefore, an overall 
increase in absorbance for the reduction of the two [2Fe-2S]2+ clus-
ters of mitoNEET by the reduced, redox-active [2Fe-2S] cluster of 
FMNH•-Ndor1/[2Fe-2S]+-anamorsin complex might be expected. 
An experimental increase in absorbance of 0.06 at 501 nm was, in-
deed, observed (Figure 1a). However, this increase is lower than 
the difference expected for the reduction of the two mitoNEET 
clusters operated by dithionite-reduced anamorsin, which has both 
[2Fe-2S] clusters reduced, i.e. 0.26 minus 0.15. This lower absorb-
ance reduction is due to the fact that, when operating with the 
Ndor1-anamorsin complex only the first, redox-active cluster of an-
amorsin is reduced. In agreement with this interpretation, by com-
paring the UV-visible spectra of dithionite-reduced anamorsin 
(Figure 1b, red line) with that of FMNH•-Ndor1/[2Fe-2S]+-
anamorsin complex (Figure 1e, orange line), it is evident that the 
absorption peaks at 423 and 458 nm, characteristic of the presence 
of anamorsin oxidized [2Fe-2S]2+ cluster,21,23 are still visible in the 
latter case, while they are bleached in the former case. 
Figure 1. Reduction of [2Fe-2S]2+ 
clusters of mitoNEET by the ana-
morsin-Ndor1 complex. (a) Kinetic 
curve of the reaction between 
FMNH•-Ndor1/[2Fe-2S]+-
anamorsin complex and oxidized 
[2Fe-2S]2+-mitoNEET at a 1:1 ratio. 
The observed variation in absorb-
ance at 501 nm was plotted as a 
function of time (black symbols) 
and fitted to a mono-exponential de-
cay function (red line) to obtain an 
apparent rate constants for one-elec-
tron transfer reaction of 40 ± 1 x 10-
5 s-1. (b) UV-visible spectra of [2Fe-
2S]2+- (black) and [2Fe-2S]+- (red) 
anamorsin. The arrow indicates the 
increase of absorbance at 501 nm 
upon oxidation (Ox) of both [2Fe-
2S] clusters of anamorsin.19,22 (c) 
UV-visible spectra of [2Fe-2S]2+- 
(black) and [2Fe-2S]+- (red) mi-
toNEET. The arrow indicates the decrease of absorbance at 501 nm upon reduction (Red) of the [2Fe-2S] clusters of mitoNEET. The proteins 
in (b) and (c) are at the same concentration used in the electron transfer reaction of (a), and were reduced with stoichiometric additions of 
sodium dithionite. (d) Kinetic curve of the reaction between FMNH•-Ndor1 and oxidized [2Fe-2S]2+-mitoNEET at a 1:1 ratio. The observed 
variations in absorbance at 501 nm was plotted as a function of time (black symbols) and fitted to a mono-exponential decay function (red 
line) to obtain an apparent rate constants for the electron transfer reaction of 45 ± 1 x 10-5 s-1. (e) UV-visible spectra of FMNH•-Ndor1/[2Fe-
2S]+-anamorsin complex mixed with [2Fe-2S]2+-mitoNEET at a 1:1 ratio after 120 min (black), FMNH•-Ndor1/[2Fe-2S]+-anamorsin com-
plex before the addition of mitoNEET (orange), [2Fe-2S]+-mitoNEET (blue), [2Fe-2S]2+-mitoNEET (green), and FMNH•-Ndor1 (brown). 
The black arrows at 584 and 630 nm indicate the absorbance peaks typical of the neutral blue semiquinone state of FMN (FMNH•). The red 
and cyano arrows indicate the increase and decrease of absorbance at 501 nm upon oxidation of the redox-active [2Fe-2S] cluster of ana-
morsin and reduction of the [2Fe-2S] clusters of mitoNEET, respectively. 
The data also showed that, in the FMNH•-Ndor1/[2Fe-2S]+-
anamorsin complex, the cofactor reducing mitoNEET clusters is 
the cluster of anamorsin, and not FMNH• of Ndor1. Indeed, if the 
reduction of [2Fe-2S]2+-mitoNEET to [2Fe-2S]+-mitoNEET were 
performed by the FMNH• group, a decrease of the absorbance at 
501 nm would be expected (i.e. only mitoNEET clusters reduction 
contributes to the overall absorbance change in such case, Figure 
1c), at variance with the increase in absorbance experimentally ob-
served (Figure 1a). This is indeed what resulted by mixing 
FMNH•-Ndor1 with [2Fe-2S]2+-mitoNEET at a 1:1 protein ratio 
where a decrease in absorbance is observed over time (Figure 1d, 
Figure S3). In agreement with the FMNH• group of the complex 
not transferring the electron to the [2Fe-2S] cluster of mitoNEET, 
the intense bands at 584 and 630 nm typical of FMNH•-Ndor1 are 
still observed once comparing the UV-visible spectrum of the final 
mixture with that of FMNH•-Ndor1 (Figure 1e, black and brown 
lines). On the contrary, the bands at 423 and 458 nm increase in the 
final mixture (Figure 1e, black line), because of the oxidation of 
the redox-active cluster of anamorsin. A simulation of the spectrum 
obtained in the final mixture, performed by linearly combining the 
UV-visible spectra of the single chromophores (i.e. FMNH•-Ndor1, 
[2Fe-2S]2+-anamorsin and [2Fe-2S]+-mitoNEET, Figure S4), con-
firms the occurrence of the electron transfer reaction between the 
two [2Fe-2S] clusters (eq 1): 
FMNH•-Ndor1/[2Fe-2S]+-anamorsin + [2Fe-2S]2+-mitoNEET   
FMNH•-Ndor1/[2Fe-2S]2+-anamorsin + [2Fe-2S]+-mitoNEET   
NMR spectroscopy was then used to investigate at molecular level 
the electron transfer process between mitoNEET and the Ndor1-
anamorsin complex. The oxidized and reduced states of [2Fe-2S]-
mitoNEET show different 1H-15N HSQC spectra (Figure S5), be-
ing the two species in slow exchange on the NMR time scale. 
Therefore, we can easily monitor the change of the cluster redox 
state. [2Fe-2S]2+-mitoNEET was first titrated with FMNH•-
Ndor1/[2Fe-2S]+-anamorsin complex. When unlabeled FMNH•-
Ndor1/[2Fe-2S]+-anamorsin complex was stepwise added to 15N la-
beled [2Fe-2S]2+-mitoNEET up to a 1:1 redox-active cluster ratio, 
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a new set of backbone NH signals appeared in the 1H-15N HSQC 
map (Figure 2a and 2b, Figure S6).  
 
Figure 2. [2Fe-2S]-mitoNEET interacts with Ndor1-anamorsin 
complex. Superimposition of the 1H-15N HSQC spectra of [2Fe-
2S]2+-mitoNEET (black contours), [2Fe-2S]+-mitoNEET obtained 
upon addition of sodium dithionite (blue contours), and [2Fe-2S]2+-
mitoNEET mixed with one equivalent of FMNH•-Ndor1/[2Fe-
2S]+-anamorsin (a and b panels, red contours), or of FMN-
Ndor1/[2Fe-2S]2+-anamorsin (c and d panels, red contours). 
These signals are very close to those of [2Fe-2S]+-mitoNEET (Fig-
ure 2a and 2b), confirming the reduction of mitoNEET by FMNH•-
Ndor1/[2Fe-2S]+-anamorsin complex, as detected by UV-visible 
spectroscopy. However, these signals are not fully overlapped with 
the corresponding signals of reduced [2Fe-2S]+-mitoNEET (Fig-
ure 2a and 2b). The small differences in chemical shifts could orig-
inate from the presence of a small fraction of the complex between 
Ndor1-anamorsin and mitoNEET. The same titration was then per-
formed with all proteins in their oxidized states in order to detect 
only protein-protein interaction effects on the NMR signals. Once 
unlabelled FMN-Ndor1/[2Fe-2S]2+-anamorsin was added to oxi-
dized 15N labeled [2Fe-2S]2+-mitoNEET up to a 1:1 redox-active 
cluster ratio, small chemical shift perturbations were observed for 
the same backbone NHs (Figure 2c and 2d, Figure S6), indicating 
that [2Fe-2S]-mitoNEET weakly interacts with the Ndor1-anamor-
sin complex. In order to define whether both or only one compo-
nent of the Ndor1-anamorsin complex interact with mitoNEET, 
15N-labeled mitoNEET was independently titrated with unlabeled 
Ndor1 and with unlabeled anamorsin. When FMN-Ndor1 was 
added to oxidized [2Fe-2S]2+-mitoNEET up to 2:1 protein-protein 
ratio, no chemical shift variations were observed in the 1H-15N 
HSQC maps (Figure 3a and 3b, Figure S6), indicating that no pro-
tein-protein interaction occurs between the two proteins. On the 
contrary, when oxidized [2Fe-2S]2+-anamorsin was added to oxi-
dized [2Fe-2S]2+-mitoNEET up to 2:1 protein-protein ratio, chem-
ical shift changes involving the same residues affected by protein-
protein interaction between the FMN-Ndor1/[2Fe-2S]2+-anamorsin 
complex and [2Fe-2S]2+-mitoNEET were observed in the 1H-15N 
HSQC maps (Figure 3c and 3d vs Figure 2c and 2d, Figure S6), 
indicating the occurrence of a specific protein-protein interaction 
between mitoNEET and anamorsin. 
 
Figure 3. [2Fe-2S]-mitoNEET interacts with anamorsin and not 
with Ndor1. Superimposition of the 1H-15N HSQC spectra of [2Fe-
2S]2+-mitoNEET (black contours), [2Fe-2S]+-mitoNEET obtained 
upon addition sodium dithionite (blue contours), and [2Fe-2S]2+-
mitoNEET mixed with one equivalent of FMN-Ndor1 (a and b 
panels, red contours), or of [2Fe-2S]2+-anamorsin (c and d panels, 
red contours). 
Mapping the backbone NHs chemical shift variations on the struc-
ture of [2Fe-2S]-mitoNEET, a well-defined region of interaction 
close to the [2Fe-2S] cluster binding site was identified, involving 
Ile 49, Gln 50, Lys 55, Ile 56 and Val 57 from loop L1, Glu 63 from 
loop L2, and Thr 94 and Asn 97 from loop L4 (Figure 4). Overall, 
the NMR data delineate a picture where [2Fe-2S]+-anamorsin com-
plexed with Ndor1 transfers electrons to the clusters of [2Fe-2S]2+-
mitoNEET via a transient, low populated protein-protein complex, 
which brings a specific region of mitoNEET containing its [2Fe-
2S] clusters close to the redox-active [2Fe-2S] cluster of anamor-
sin. 
 
Figure 4. The region of [2Fe-2S]-mitoNEET interacting with ana-
morsin. The [2Fe-2S] clusters and the atoms of the residues of 
[2Fe-2S]-mitoNEET showing chemical shift variations upon [2Fe-
2S]-anamorsin interaction are represented as spheres with conven-
tional CPK color code on the crystal structure of [2Fe-2S]-mi-
toNEET (PDB ID 2QH7). 
Recent studies have shown that: i) the [2Fe-2S] clusters of mi-
toNEET are assembled by the mitochondrial ISC assembly machin-
ery and by the export machinery, with no apparent connection with 
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the CIA machinery;11 ii) mitoNEET is an Fe/S transfer/repair sys-
tem, playing such a role exclusively under conditions of oxidative 
stress;11 iii) the process of cluster transfer is initiated only by chang-
ing the redox state of the mitoNEET clusters from the reduced 
[2Fe-2S]+ to the oxidized [2Fe-2S]2+ form.7 Here, we suggest that 
the Ndor1-anamorsin complex, by reducing mitoNEET clusters, 
might act as a regulator of the termination of the cluster transfer 
reaction from mitoNEET to IRP1. Once oxidative stress is not pre-
sent anymore, the Ndor1-anamorsin complex of the CIA machinery 
is formed in the cytoplasm20 and converts back mitoNEET into its 
reduced [2Fe-2S]+ form. In this way, the CIA machinery stops the 
mitoNEET-cluster transfer pathway to repair IRP1, as the repairing 
function of mitoNEET is no longer needed. This “stop” message 
directs both mitochondrial ISC assembly and export machineries to 
function exclusively for the CIA machinery. Upon mitoNEET clus-
ter reduction, these mitochondrial machineries are, indeed, not an-
ymore working on mitoNEET-driven IRP1 repairing pathway.7 It 
is possible that a direct link between the CIA pathway and mi-
toNEET-cluster transfer pathway might be required to restore CIA 
machinery efficiency to mature cytosolic and nuclear Fe/S proteins. 
The present in vitro finding and our hypothesis of a link between 
these two pathways could constitute the basis for cellular studies 
verifying the occurrence of this connection at cellular level. 
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